A 61-year-old patient, initially presenting with urinary complaints, has undergone Stereotactic Body Radiation Therapy (SBRT) for prostate cancer at KMC Hospital Attavar Oncology Centre (KMCHAOC) in ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...

ALTON The statistics surrounding the incidence rate of lung cancer nationally, state-wide, and locally can literally take your breath away.According to ...

Aside from that intensely intimate storyline, what we noted was the absence of Craig Parkinson's Norman Potting. It was ...

While John Simm, Richie Campbell, Zoë Tapper, Laura Elphinstone and Brad Morrison were all back as their characters, Craig ...

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, April 14, 2025 /PRNewswire/ -- ...

Company to present updated preliminary results from ENLIGHTED Phase 3 Study in LG UTUC -- Additional podium presentation to provide updates ...

Q4 2024 Earnings Call Transcript March 27, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.29. Operator: Good morning. And welcome to PDS ...

Mesoblast soon should generate first revenue from Ryoncil, while Telix expects FDA approvals beyond its prostate cancer indications ... with chemotherapy, for advanced pancreatic cancer. Narmafotinib ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced the creation of a new Sarcoma Subcommittee ...

Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional ...

Dr. Noel Clarke discussed the use of intensified approaches with radiation therapy for the contemporary management of locally advanced prostate cancer. What are the relevant questions for radiotherapy ...